Blood Cancer

HKUMed successfully conducts the first CAR-T cell therapy in Hong Kong for end-stage multiple myeloma using an advanced … HKU Li Ka Shing Faculty of Medicine (Press Release)05:46
Elotuzumab-based regimen demonstrates efficacy in relapsed/refractory multiple myeloma Pharmacy Times16:48
Genetic study sheds light on inherited risk of multiple myeloma Pharmacy Times14:54
Gene editing for safer CAR T-cell therapy in large B-cell lymphoma American Journal of Managed Care14:09
Outcomes and prognostic factors in patients with Burkitt lymphoma/leukemia in adolescents and adults: an experience… Nature.com23:43
Off-the-shelf CAR T-cell therapy p-bcma-ALLO1 is efficacious in relapsed/refractory multiple myeloma OncLive08:16

Latest News

In the last half-hour
Korean hematologists urge faster reimbursement for lifesaving blood cancer drugs Korea Biomedical Review03:07
Yesterday
Long-Term Follow-Up Data from the CASSIOPEIA Trial Show Continued MRD, PFS Benefit in Multiple Myeloma Pharmacy Times13:14 26-Mar-25
HKUMed successfully conducts the first CAR-T cell therapy in Hong Kong for end-stage multiple myeloma using an advanced … HKU Li Ka Shing Faculty of Medicine (Press Release)05:46 26-Mar-25
In the last 7 days
Multiple Myeloma Awareness Month: Symptom Recognition and Understanding Precursor Conditions Are Key for Diagnosis OncLive17:17 25-Mar-25
A new CAR-T-cell therapy tricks cancer cells with a decoy to increase treatment efficiency in… ecancer12:23 25-Mar-25
Making Bispecific Therapies Work in Community Settings American Journal of Managed Care10:22 25-Mar-25
Free workshop for people with blood cancer in Dorset Bournemouth Daily Echo01:18 25-Mar-25
Researchers develop TIM-3 decoy to enhance CAR-T therapy effectiveness for B-ALL tumors News-Medical.Net21:20 24-Mar-25
Cali rings the bell to mark the end of cancer treatment Lewisham and Greenwich NHS Trust (Press Release)08:33 24-Mar-25
Correlation of progression-free survival and overall survival after treatment for relapsed Hodgkin lymphoma: individual … Nature.com05:01 24-Mar-25
Woman thought symptoms were grief before diagnosis after asking Chat Gpt Plymouth Live13:58 23-Mar-25
'I thought my symptoms were being caused by anxiety and grief - but then Chat Gpt diagnosed me… Manchester Evening News13:33 23-Mar-25
Five Under 5: Top Oncology Videos for the Week of 3/16 OncLive10:50 23-Mar-25
Antiepileptic drugs failed to prevent initial seizures or improve survival outcomes in patients with primary CNS… Nature.com05:37 23-Mar-25
The type of fitness tracker that can spot the early signs of cancer - are you wearing one? MailOnline09:43 22-Mar-25
Gaucher Disease: A Rare Disease Sheds Light on More Common Conditions Yale Medicine16:10 21-Mar-25
BCMA-Targeting CAR T-Cell Therapy Is Feasible in Patients With Multiple Myeloma and CNS Involvement Pharmacy Times15:56 21-Mar-25
Streamlining "Brain-to-Vein" Time, Patient Selection, Imperative for Implementing CAR T for MM American Journal of Managed Care12:56 21-Mar-25
NMPA Grants Conditional Approval to Tazemetostat for EZH2-Mutant R/R Follicular Lymphoma OncLive11:51 21-Mar-25
China conditionally approves Hutchmed’s Tazverik for follicular lymphoma Pharmaceutical Technology11:14 21-Mar-25
Tattoos Could Be a Hidden Cancer Risk, Study of Twins Finds Gizmodo10:49 21-Mar-25
Overcoming CAR T Manufacturing Failure in LBCL American Journal of Managed Care10:13 21-Mar-25
Hutchmed Announces NMPA Conditional Approval for Tazverik® (tazemetostat) for the Treatment of Relapsed or Refractory… GlobeNewswire (Press Release)06:02 21-Mar-25
'It’s made me who I am': Ellen Deegan on how hope blossoms during cancer treatment Irish Examiner22:06 20-Mar-25
Disparities in Multiple Myeloma Distress Screenings May Point to Care Gaps American Journal of Managed Care17:36 20-Mar-25
FDA Grants Fast Track Designation to Azer-Cel for R/R DLBCL OncLive11:17 20-Mar-25
Amanda Mealing's solicitor reveals devastating cancer diagnosis after cocaine-fuelled crash The Mirror08:56 20-Mar-25
In the last month
Prevalence of hematological malignancies in Africa: A systematic review and meta-analysis Nature.com10:34 19-Mar-25
Orca Bio makes a splash as T-cell therapy cuts GvHD in blood cancer patients Clinical Trials Arena10:10 18-Mar-25
Off-the-Shelf CAR T-Cell Therapy P-BCMA-ALLO1 Is Efficacious in Relapsed/Refractory Multiple Myeloma OncLive08:16 18-Mar-25
Elotuzumab-Based Regimen Demonstrates Efficacy in Relapsed/Refractory Multiple Myeloma Pharmacy Times16:48 17-Mar-25
Gene Editing for Safer CAR T-Cell Therapy in Large B-Cell Lymphoma American Journal of Managed Care14:09 17-Mar-25
Bristol Myers Squibb granted EC approval for Breyanzi in follicular lymphoma PMLiVE08:53 17-Mar-25
Dumfries and Galloway motorbike run aims to raise money for Blood Cancer UK Daily Record07:09 17-Mar-25
EC approves Bristol Myers Squibb’s follicular lymphoma CAR T therapy Clinical Trials Arena04:22 17-Mar-25
‘I was in bed for a year’: Cancer survivor calls for $220k-a-year drug to be funded New Zealand Herald23:11 16-Mar-25
StockWatch: Will BMS–2seventy Deal Prove a Win-Win? Genetic Engineering and Biotechnology News11:16 16-Mar-25
Young mum tragically dies after battling cancer through pregnancy Daily Record00:37 15-Mar-25
Outcomes and prognostic factors in patients with Burkitt lymphoma/leukemia in adolescents and adults: an experience… Nature.com23:43 14-Mar-25
Liso-Cel Receives European Approval in Relapsed/Refractory Follicular Lymphoma OncLive12:13 14-Mar-25
80-year-old cancer patient defies illness by taking up ballet Lynn News10:35 14-Mar-25
Atezolizumab, Immunogenic Chemotherapy Combination Shows Promise for DLBCL Treatment American Journal of Managed Care10:14 14-Mar-25
Romford teacher, 27, on how writing helped her with cancer 'catastrophe' Romford Recorder02:07 14-Mar-25
Genetic Study Sheds Light on Inherited Risk of Multiple Myeloma Pharmacy Times14:54 13-Mar-25
Amgen’s Blincyto OKed for consolidation therapy in ALL, shifting treatment paradigm Korea Biomedical Review22:11 12-Mar-25
Ono earmarks $940m to gain rare blood cancer therapy from Ionis Pharmaceutical Technology15:27 12-Mar-25
Dexamethasone Shows Promise as Cost-Effective Alternative to Tocilizumab for Cytokine Release Syndrome in RRMM Pharmacy Times14:00 12-Mar-25
Emeritus Professor recognised for outstanding research in genetics and epigenetics in blood cancer University of Birmingham13:18 12-Mar-25
Anti-CD38-CAR-γδ T Cells Show Preclinical Cytotoxicity in Myeloma OncLive10:23 12-Mar-25
Dying for attention: Why do some people pretend to be sick? WA Today22:03 11-Mar-25
Meet the Endurance Athletes Going the Extra Mile to Fight Cancer Outside14:27 11-Mar-25
BMS to Acquire Abecma Partner 2seventy bio for $286M Genetic Engineering and Biotechnology News14:15 11-Mar-25
Frequent Blood Donors Have Healthier Blood Cells and More Protection Against Cancer ZME Science13:06 11-Mar-25
Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical Mrd Detection in… GlobeNewswire (Press Release)08:01 11-Mar-25
Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights GlobeNewswire (Press Release)07:10 11-Mar-25
Giving blood frequently may make your blood cells healthier New Scientist06:02 11-Mar-25
Researchers Find New Drug Combination Could Be More Effective for Myelofibrosis Newswise (Press Release)09:55 10-Mar-25
New drug combo could fight aggressive blood cancer Knowridge Science Report06:38 10-Mar-25
GLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patients News-Medical.Net21:38 9-Mar-25
Press Release: Sarclisa is the first anti-CD38 treatment in combination with standard-of-care VRd approved in China for … Sanofi (Press Release)06:31 9-Mar-25
Overcoming Delays in CAR T for Large B-Cell Lymphoma American Journal of Managed Care17:25 7-Mar-25
Pharmacists Play an Essential Role in Bispecific Therapy for Multiple Myeloma Pharmacy Times16:21 7-Mar-25
Risk for Lymphoma, Skin Cancer Increased in Individuals With Tattoos HealthDay12:08 7-Mar-25
Liso-Cel Prolongs Responses, PFS, and OS in Pretreated, High-Risk R/R CLL American Journal of Managed Care11:19 7-Mar-25
Takeda/Protagonist share positive phase 3 results for rusfertide in rare blood cancer PMLiVE07:25 7-Mar-25
Tattoos might increase skin cancer, lymphoma risk, study finds UPI10:57 6-Mar-25
Tattoos Might Increase Lymphoma, Skin Cancer Risk NewsMax07:50 6-Mar-25
Regeneron receives positive CHMP opinion for linvoseltamab in multiple myeloma PMLiVE07:29 6-Mar-25
Tattoos Might Increase Risk of Lymphoma, Skin Cancer HealthDay06:49 6-Mar-25
Antengene expands commercial presence in APAC with XPOVIO's approval in Indonesia for cancer treatment BioSpectrum Asia22:48 5-Mar-25
Could a Tattoo Raise Your Risk of Skin Cancer? Twin Studies Suggest a Link. ScienceAlert19:19 5-Mar-25
Comparative Oncology: Advances in Cancer Care from Pets to Humans Pharmacy Times15:11 5-Mar-25
Daratumumab Plus VRd Yields Deep, Durable Responses in Patients with NDMM Pharmacy Times13:16 4-Mar-25
How tattoo ink travels through the body, raising risks of skin cancer and lymphoma Study Finds10:41 4-Mar-25
Tattoos Could Increase Risk Of Certain Cancers, Study On Twins Reveals IFLScience10:39 4-Mar-25
HealthTree introduces AI-powered tool to match myeloma patients with trials Clinical Trials Arena08:24 4-Mar-25
J&J receives three CHMP recommendations for immunology and oncology indications PMLiVE07:35 4-Mar-25
Bispecific T-cell engagers (BiTE) significantly prolong survival in multiple myeloma patients: study Korea Biomedical Review21:17 3-Mar-25
EMA Gives Positive Opinion to Lilly Treatment for Chronic Lymphocytic Leukemia PharmTech.com15:40 3-Mar-25
Protagonist says Takeda-partnered drug succeeds in rare blood cancer BioPharma Dive11:48 3-Mar-25
Takeda scores with polycythemia vera drug in phase 3 trial pharmaphorum09:24 3-Mar-25
For Your Patients: What Is Multiple Myeloma? Medpage Today09:06 3-Mar-25
The Basics of Multiple Myeloma Medpage Today09:06 3-Mar-25
Blinatumomab gains backing for MRD-negative ALL British Society for Haematology04:42 3-Mar-25
Blood cancer patients face treatment access disparity PharmaTimes04:34 3-Mar-25
Detailed study of lymphoma acquired from CAR-T therapy British Society for Haematology04:32 3-Mar-25
Five Under 5: Top Oncology Videos for the Week of 2/23 OncLive08:19 2-Mar-25
CHMP Recommends Subcutaneous Daratumumab Plus VRd for Newly Diagnosed Myeloma OncLive13:56 28-Feb-25
CHMP Recommends Conditional Approval of Linvoseltamab for R/R Multiple Myeloma OncLive11:23 28-Feb-25
Chmp recommends EU approval of Roche’s Columvi combination for people with relapsed or refractory diffuse large B-cell… GlobeNewswire (Press Release)08:18 28-Feb-25
Johnson & Johnson’s Darzalex® (daratumumab) subcutaneous-based regimen receives positive Chmp opinion for patients with … GlobeNewswire (Press Release)08:03 28-Feb-25
Linvoseltamab Recommended for EU Approval by the Chmp to Treat Relapsed/Refractory Multiple Myeloma GlobeNewswire (Press Release)07:01 28-Feb-25
The Rapid Evolution of Multiple Myeloma Treatment in Recent Years OncLive15:13 27-Feb-25
Lisocabtagene Maraleucel Expands the Therapeutic Landscape for Relapsed/Refractory Non-Hodgkin Lymphoma Pharmacy Times10:11 27-Feb-25
Cost-Effectiveness Strategies Vital for Streamlining Care in Hematologic Malignancies American Journal of Managed Care09:23 27-Feb-25
Regeneron makes second bid for blood cancer therapy approval Pharmaceutical Technology07:11 27-Feb-25
Regeneron tries again with lymphoma bispecific in US pharmaphorum06:45 27-Feb-25
Deep Responses in Smoldering Multiple Myeloma Linked to Improved Outcomes Pharmacy Times15:03 26-Feb-25
FDA Accepts Resubmission of BLA for Odronextamab in R/R Follicular Lymphoma OncLive12:29 26-Feb-25
Bell signals end of cancer treatment for Oscar Medway NHS Foundation Trust (Press Release)11:44 26-Feb-25
Isatuximab Plus VRd Wins Japanese Approval for Newly Diagnosed Myeloma OncLive09:35 26-Feb-25
Amgen’s Blincyto recommended by NICE for new adult leukaemia indication PMLiVE07:32 26-Feb-25
Odronextamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma Regeneron Pharmaceuticals (Press Release)07:02 26-Feb-25
Immune signature and pathways investigation of adrenal gland diffuse large B-cell lymphoma Nature.com21:57 25-Feb-25
2025 Cancer in Iowa report shines spotlight on cancer survivors and their needs Iowa Capital Dispatch19:08 25-Feb-25
Automated Endoscopic Device Obtains Improved Biopsy Results in Single Pass Hospimedica10:18 25-Feb-25
NICE recommends Bristol Myers Squibb’s lymphoma treatment Pharmaceutical Field07:32 25-Feb-25
Press Release: Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma GlobeNewswire (Press Release)01:02 25-Feb-25
Nice recommends novel immunotherapy for leukaemia European Pharmaceutical Review21:30 24-Feb-25
Home and Away star Tessa James gives an update on her cancer diagnosis after suffering from… MailOnline18:37 24-Feb-25
How One Couple Navigated a Rare Blood Cancer Prevention.com16:47 24-Feb-25
Optimizing Approaches to CAR T, Bispecific Therapies in Myeloma and Lymphoma American Journal of Managed Care14:03 24-Feb-25
Allogeneic vs Autologous CAR T-Cell Therapy Explained American Journal of Managed Care10:29 24-Feb-25
CSHL receives $100K for leukemia research Cold Spring Harbor Laboratory07:36 24-Feb-25
Rare side effect of cancer immunotherapy ecancer05:44 24-Feb-25

      
            
      
    view more headlines
   
      
      
      
27 Mar 03:07
   

Blood Cancer

Latest News

Cancer Top Stories

Health Top Stories

Lifestyle Top Stories